In established atherosclerosis, P2Y12 inhibitor vs. aspirin monotherapy reduces MI but not stroke or mortality.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 32926821.
- Also identified by DOI 10.7326/ACPJ202009150-026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chiarito M, Sanz-Sánchez J, Cannata F, et al. <b>Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.</b> Lancet. 2020;395;1487-95. 32386592.
Medical subject headings
- Atherosclerosis
- Percutaneous Coronary Intervention
- Stroke